These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 870271)

  • 1. A standard approach to compiling clinical pharmacokinetic data.
    Sheiner LB; Benet LZ; Pagliaro LA
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):59-127. PubMed ID: 7014827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal clearance of digoxin in man after sodium loading or furosemide treatment.
    Naafs MA; van der Hoek C; Schopman W; van Duin S; Koorevaar G; Silberbusch J
    Eur J Clin Pharmacol; 1983; 25(3):375-9. PubMed ID: 6628526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions with digoxin.
    Rodin SM; Johnson BF
    Clin Pharmacokinet; 1988 Oct; 15(4):227-44. PubMed ID: 3056649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin, whole body potassium and the electrocardiogram.
    Joubert PH; Müller FO; van Rijssen FW; Malan J; Iturralde MP; van Reenen OR
    Eur J Clin Pharmacol; 1978 Nov; 14(2):101-4. PubMed ID: 720374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of furosemide on serum clearance and renal excretion of digoxin.
    Tsutsumi E; Fujiki H; Takeda H; Fukushima H
    J Clin Pharmacol; 1979 Apr; 19(4):200-4. PubMed ID: 438354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of furosemide on the renal excretion of digoxin.
    Brown DD; Dormois JC; Abraham GN; Lewis K; Dixon K
    Clin Pharmacol Ther; 1976 Oct; 20(4):395-400. PubMed ID: 975715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of furosemide on beta-methyl-digoxin excretion in the urine (author's transl)].
    Baczýnski R; Kokot F
    Dtsch Med Wochenschr; 1978 Apr; 103(15):662-4. PubMed ID: 639708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous furosemide on the renal excretion of digoxin.
    McAllister RG; Howell SM; Gomer MS; Selby JB
    J Clin Pharmacol; 1976; 16(2-3):110-7. PubMed ID: 943423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone-induced changes in digoxin kinetics.
    Waldorff S; Andersen JD; Heebøll-Nielsen N; Nielsen OG; Moltke E; Sørensen U; Steiness E
    Clin Pharmacol Ther; 1978 Aug; 24(2):162-7. PubMed ID: 679595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin kinetics during furosemide administration.
    Malcolm AD; Leung FY; Fuchs JC; Duarte JE
    Clin Pharmacol Ther; 1977 May; 21(5):567-74. PubMed ID: 870271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and interactions of digoxin, theophylline and furosemide in diseases with edema.
    Macolić V; Vrhovac B
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):6-11. PubMed ID: 8444517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of spironolactone and digoxin: a review and evaluation.
    Thomas RW; Maddox RR
    Ther Drug Monit; 1981; 3(2):117-20. PubMed ID: 7022769
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.